Cameron Turtle Insider Trading $EIDX Eidos Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Cameron Turtle.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cameron Turtle. Cameron Turtle is Chief Business Officer in Eidos Therapeutics, Inc. ($EIDX) and See Remarks in BridgeBio Pharma, Inc. ($BBIO).
Cameron Turtle in Eidos Therapeutics, Inc.
Trading Symbol: EIDXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cameron Turtle: Chief Business Officer
Holdings: 0 shares
Latest Transaction: Jan 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Cameron Turtle in Eidos Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | D | 13.20 | 53,157 | 701,672 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | D | 17.00 | 9,469 | 160,973 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | U | 0.00 | 50,699 | 0 | 0 | 50.7 K to 0 (-100.00 %) |
Dec 16 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | M | 13.20 | 21,843 | 288,328 | 53,157 | |
Dec 16 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | M | 17.00 | 4,451 | 75,667 | 9,469 | |
Dec 16 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 112.97 | 3,493 | 394,589 | 50,621 | 54.1 K to 50.6 K (-6.45 %) |
Dec 16 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 112.19 | 11,445 | 1,284,018 | 54,114 | 65.6 K to 54.1 K (-17.46 %) |
Dec 16 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 111.31 | 7,600 | 845,937 | 65,559 | 73.2 K to 65.6 K (-10.39 %) |
Dec 16 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 110.29 | 3,756 | 414,251 | 73,159 | 76.9 K to 73.2 K (-4.88 %) |
Dec 16 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Buy | M | 13.20 | 21,843 | 288,328 | 76,915 | 55.1 K to 76.9 K (+39.66 %) |
Dec 16 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Buy | M | 17.00 | 4,451 | 75,667 | 55,072 | 50.6 K to 55.1 K (+8.79 %) |
Nov 13 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Gift | G | 0.00 | 1,500 | 0 | 50,621 | 52.1 K to 50.6 K (-2.88 %) |
Nov 13 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 75.23 | 908 | 68,308 | 52,121 | 53 K to 52.1 K (-1.71 %) |
Nov 13 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 74.75 | 9,497 | 709,860 | 53,029 | 62.5 K to 53 K (-15.19 %) |
Nov 13 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 73.56 | 3,005 | 221,060 | 62,526 | 65.5 K to 62.5 K (-4.59 %) |
Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | M | 17.00 | 2,500 | 42,500 | 13,920 | |
Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | M | 13.20 | 5,000 | 66,000 | 75,000 | |
Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 72.10 | 209 | 15,068 | 65,531 | 65.7 K to 65.5 K (-0.32 %) |
Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 71.42 | 3,146 | 224,677 | 65,740 | 68.9 K to 65.7 K (-4.57 %) |
Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 70.44 | 9,145 | 644,209 | 68,886 | 78 K to 68.9 K (-11.72 %) |
Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Buy | M | 17.00 | 2,500 | 42,500 | 78,031 | 75.5 K to 78 K (+3.31 %) |
Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Buy | M | 13.20 | 5,000 | 66,000 | 75,531 | 70.5 K to 75.5 K (+7.09 %) |
Sep 11 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | M | 17.00 | 2,500 | 42,500 | 16,420 | |
Sep 11 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 47.00 | 2,500 | 117,500 | 70,531 | 73 K to 70.5 K (-3.42 %) |
Sep 11 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Buy | M | 17.00 | 2,500 | 42,500 | 73,031 | 70.5 K to 73 K (+3.54 %) |
Aug 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | M | 13.20 | 5,000 | 66,000 | 80,000 | |
Aug 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 40.89 | 500 | 20,446 | 70,531 | 71 K to 70.5 K (-0.70 %) |
Aug 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 40.25 | 6,700 | 269,672 | 71,031 | 77.7 K to 71 K (-8.62 %) |
Aug 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 39.05 | 2,800 | 109,332 | 77,731 | 80.5 K to 77.7 K (-3.48 %) |
Aug 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Buy | M | 13.20 | 5,000 | 66,000 | 80,531 | 75.5 K to 80.5 K (+6.62 %) |
Jun 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Grant | A | 41.57 | 376 | 15,632 | 75,531 | 75.2 K to 75.5 K (+0.50 %) |
May 28 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | M | 17.00 | 2,500 | 42,500 | 18,920 | |
May 28 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 47.00 | 2,500 | 117,500 | 75,155 | 77.7 K to 75.2 K (-3.22 %) |
May 28 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Buy | M | 17.00 | 2,500 | 42,500 | 77,655 | 75.2 K to 77.7 K (+3.33 %) |
May 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | M | 13.20 | 5,000 | 66,000 | 85,000 | |
May 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 43.26 | 20 | 865 | 75,155 | 75.2 K to 75.2 K (-0.03 %) |
May 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 42.56 | 1,180 | 50,220 | 75,175 | 76.4 K to 75.2 K (-1.55 %) |
May 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 41.23 | 1,050 | 43,287 | 76,355 | 77.4 K to 76.4 K (-1.36 %) |
May 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 40.52 | 7,750 | 314,061 | 77,405 | 85.2 K to 77.4 K (-9.10 %) |
May 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Buy | M | 13.20 | 5,000 | 66,000 | 85,155 | 80.2 K to 85.2 K (+6.24 %) |
Feb 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | M | 17.00 | 2,500 | 42,500 | 21,420 | |
Feb 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | M | 13.20 | 5,000 | 66,000 | 90,000 | |
Feb 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 53.89 | 7,211 | 388,636 | 80,155 | 87.4 K to 80.2 K (-8.25 %) |
Feb 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 53.32 | 5,289 | 282,004 | 87,366 | 92.7 K to 87.4 K (-5.71 %) |
Feb 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Buy | M | 17.00 | 2,500 | 42,500 | 92,655 | 90.2 K to 92.7 K (+2.77 %) |
Feb 05 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Buy | M | 13.20 | 5,000 | 66,000 | 90,155 | 85.2 K to 90.2 K (+5.87 %) |
Dec 10 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | M | 13.20 | 10,000 | 132,000 | 95,000 | |
Dec 10 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 59.43 | 8,900 | 528,922 | 85,155 | 94.1 K to 85.2 K (-9.46 %) |
Dec 10 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 58.28 | 700 | 40,794 | 94,055 | 94.8 K to 94.1 K (-0.74 %) |
Dec 10 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 56.84 | 400 | 22,736 | 94,755 | 95.2 K to 94.8 K (-0.42 %) |
Dec 10 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Buy | M | 13.20 | 10,000 | 132,000 | 95,155 | 85.2 K to 95.2 K (+11.74 %) |
Sep 06 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 42.09 | 643 | 27,064 | 95,155 | 95.8 K to 95.2 K (-0.67 %) |
Sep 06 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 41.51 | 4,357 | 180,859 | 95,798 | 100.2 K to 95.8 K (-4.35 %) |
Jun 06 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 32.27 | 3,300 | 106,491 | 100,155 | 103.5 K to 100.2 K (-3.19 %) |
Jun 06 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 31.33 | 6,700 | 209,911 | 103,455 | 110.2 K to 103.5 K (-6.08 %) |
Jun 06 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Grant | A | 12.01 | 1,769 | 21,246 | 110,155 | 108.4 K to 110.2 K (+1.63 %) |
Jun 06 2019 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Grant | A | 12.01 | 1,081 | 12,983 | 108,386 | 107.3 K to 108.4 K (+1.01 %) |
Page: 1